Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, operates as a healthcare company. With a market cap of $12.1 billion, the company produces medicines for patients across a broad range of major therapeutic areas spanning both noncommunicable and infectious diseases. The global healthcare giant is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Thursday, Nov. 6. Ahead of the event, analysts expect VTRS to report a profit of$0.63 per share on a dilut ...